Dongsung Pharm (002210) — Strategic Asset Allocation Index
Dongsung Pharm (002210) has a Strategic Asset Allocation Index of 50.5% as of June 2013. Strategic assets (PP&E of ₩32.51 Billion plus long-term investments of ₩-) total ₩32.51 Billion, measured against net assets of ₩64.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Dongsung Pharm (002210) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Dongsung Pharm Strategic Asset Allocation Index (2008–2011)
This chart shows how Dongsung Pharm's Strategic Asset Allocation Index has evolved across 4 annual periods from 2008 to 2011. As of June 2013, the index stands at 50.5%, representing strategic assets of ₩32.51 Billion against net assets of ₩64.39 Billion KRW. For live market cap and overall valuation, see Dongsung Pharm (002210) market capitalisation.
Annual Strategic Asset Allocation Index for Dongsung Pharm (2008–2011)
The table below presents the year-by-year Strategic Asset Allocation Index for Dongsung Pharm from 2008 to 2011, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002210 book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2011 | 52.8% | ₩31.78 Billion | ₩30.62 Billion | ₩1.16 Billion | ₩60.20 Billion | ▲ +3.7 pp |
| 2010 | 49.1% | ₩29.03 Billion | ₩27.67 Billion | ₩1.37 Billion | ₩59.10 Billion | ▼ -24.2 pp |
| 2009 | 73.3% | ₩49.85 Billion | ₩47.70 Billion | ₩2.15 Billion | ₩67.97 Billion | ▼ -0.5 pp |
| 2008 | 73.9% | ₩50.12 Billion | ₩48.25 Billion | ₩1.87 Billion | ₩67.82 Billion | — |